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of collateral vessels and exertion of ischemic preconditioning, but irreversible ischemia 
damages the heart such as necrosis or apoptosis. In the mice head, it is impossible to 
create low coronary flow (reversible) conditions, leading us to use canine hearts. How- 
ever, it has been also difficult o examine the multiple gene expressions in canine hearts. 
To solve this difficulty, we succeeded in the development of canine DNA microarray, and 
tested the ability of this method to distinguish the subtle but essential differences in the 
pathophysiological conditions of the heart. About sixty cardiovascular elated genes were 
cloned using PCR method from our newly developed beagle dog cDNA library, and spot- 
ted on CMToGAPS slides. PCR fragments were chosen to amplify the specific, non-over- 
lapping open-reading frame of each cDNA. Using the arrays, we analyzed the expression 
profile of canine myooardium in two protocols, 1) necrotic myocardium caused by total 
LAD ligation for 3 hours (edual to mice necrosis model), and 2) ischemic myocardium of 
50% LAD blood flow reduction (equal to angina pectoris of human). Three hours after 50 
% coronary flow reduction, cardiovascular elated genes were changed rapidly and the 
number of upregulated genes was much more than the case of complete coronary occlu- 
sion. These genes included ecto-5'-nucleotidase, endothelin-1, PAl-l, AT1 and AT2 
receptors, PKC e. However, in the necrotic tissue, these gene expressions was almost 
lost. This indicates that ischemic damage without necrosis affects the gene expressions 
stronger on the survived myocardium than fatally damaged myocardium. These data 
suggest that canine DNA microarray provides the novel tool to assess the precise molec- 
ular events following the changes in physiological conditions. 
1099-29 Reduction of Myocardial Infarct Size by a HMG CoA- 
Reductase Inhibitor in Normocholesterolemic Rats 
Sebastian Wolfrum, Michael Grimm, Marc Heidbreder, Andreas Dendorfer, Hugo A. 
Katus, James K. Lied, Gert Richardt, Medical Clinic II and Institute of Pharmacology, 
University of L~beck, Ldbeck, Germany, Department of Vascular Medicine, Brigham & 
Women's Hospital, Boston, Massachusetts. 
Backround: In addition to their lipid lowering properties, statins improve endothelial func- 
tion by increasing the activity of endothelial nitric oxide synthase (eNOS). We hypothe- 
sized, that by this mechanism statins may protect he myocardium from ischemic injury. 
Methods: Anaesthetised rats underwent 30 min of coronary artery occlusion (CAd) fol- 
lowed by 180 min of reperfusion. Heart rate and arterial blood pressure were continu- 
ously monitored throughout he expedments. Plasma cholesterol concentrations were 
determined at the end of the experiments. Infarct size was measured by TTC staining 
and expressed as percentage of area at risk. Myocardial eNOS activity was measured by 
arginine to citrulline conversion assay. The rats were pretreated for one week either with 
cerivastatin (0.3 mgkg'ld "1) or placebo. In one set of experiments L-NAME (15 mgkg'l), 
an inhibitor of eNOS, was applicated 15 rain prior to CAd. Results: Cerivaatatin 
increased myocardial eNOS activity by 58% (12 -+ 1 to 19 + 2 pmol/mg/min, p,:0.05) and 
decreased infarct size by 49% (59 ± 7% to 29 ± 5%, p<0,05) without affecting hemody- 
namics or plasma cholesterol evels. Cardioprotection and uprogulation of eNOS activity 
were absent in rats co-treated with L-NAME. Conclusion: Statins reduce the extent of 
myocardial necrosis after acute ischemia/reperfusion i jury by increasing myocardial 
eNOS activity. 
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1099-30 Slmvastatin Restores Endothelial Nitric Oxide Mediated 
Vasorelaxation in Large Arteries After Myocardial 
Infarction 
Kathrvn Bates. Steven Goldman, Mohemed Gaballa, SAVAHCS, Tucson, Arizona. 
Congestive heart failure (CHF) after myocardial infarction (MI) is associated with dimin- 
ished endothelial nitric oxide (NO)-mediated vasorelaxation. The 3-hydroxy-3 methylglu- 
taryl CoA reductase inhibitors have been shown to modulate vascular tone, independent 
of their effects on lipid lowering. We hypothesized that simvastatin restores NO-depen- 
dent vasorelaxation after MI, produced by coronary artery ligation, via uprogulation of 
endothelial nitric oxide synthase (eNOS). We found that compared to normal arterial tis- 
sue incubated with culture medium only, incubation with 0.1 mM of simvastatin for 24 
hours enhanced acetylcholine (ACh)-mediated vasorelaxation (P<0.05) with peak 
observed at 10 ,4 M (60~11% vs 33.7±7.8%, n=6; P<0.05). Compared to untreated rats, 
simvastatin increased eNOS protein content by over 200% (62.0~-t 4.0 % vs 21.6-+7.9 %, 
II/mg protein, P<0.05). In endothelial celts in culture, 10 mM and 20 mM of simvastatin 
increased eNOS Jevels by 114.7±39.9% and 212.0+75.0% H/rag protein, n=6, P<0.05, 
respectively, in CHF rats treated by oral gavage with simvastatin (20 mg/kg/day) for three 
weeks, mean artedal pressure (105 -+ 5.75 vs 96.5 -+ 10.SmmHg) and LV dP/dt (4288 + 
672, vs 4091 -+ 1064 mmHg/sec, N--6) were decreased (P<0.05). Treatment of CHF rats 
with simvastatin reduced basal vasoconstriction and improved (P<0.05) the ACh-medi- 
ated vasorelaxation with a maximal response of 66.8 -+ 5.7% vs 32.6 -+ 6.8%, N=7, 
respectively. Inhibition of NO generation using 100 mM NG-nitro-L-arginine methyl ester 
(L-NAME) abolished the ACh-induced vasorelaxation in all rats. Our data suggest that 
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after 24 hour incubation with simvastatin in thoracic aodic segments and endothelial ceils 
in culture, endothelial dependent vasorelaxation is enhanced via up-regulation of endot- 
helial eNOS. More importanUy, chronic treatment with simvastatin restores endothelial 
NO-dependent dysfunction in heart failure rats. 
1099-31 Inhibitory Effects of the Novel Antagonist of Both GP 
lib/Ilia and Vitronectin Receptors on the Formation of 
Coronary Thromboemboli Caused by an Inhibition of 
Adenosine Receptors During Coronary Hypoperfusion 
in Dogs 
Hiroshi Asanuma, Masafumi Kitakaze, Koichi Node, Shoji Saneda, Hisakazu Ogita, Seiji 
Takashima, Masanori Asakura, Tetsuo Minamino, Michihiko Tada, Masatsugu Hod, 
Osaka University Graduate School of Medicine, Suita, Japan, National Cardiovascular 
Center, Suita, Japan. 
Background: Platelet glycoprotein (GP) lib/Ilia is a membrane receptor for fibrinogen 
and yon Willebrand factor, which plays an important role in platelet aggregation. Intogrin 
(xV~,3, vitronectin receptor, mediates adhesion and migration of many types of cells, such 
as vascular cells, and laukocytes. The activation of platelets and the formation of neutro- 
phU-platelet conjugates may lead to the development of thromboemboli. We have previ- 
ously reported that endogenous adenosine inhibits P-selectin-dependerd formation of 
coronary thromboemboU during hypoperfusion in dogs, we examined whether the CP 
compound, a novel antagonist of both GP lib/Ilia and vitronectin receptors appears to 
inhibit he formation of thromboemboli during coronary hypopeffusion. 
Methods and Results: When 8-sulfophenyltheophylline (8-SPT), an adenosine receptor 
antagonist, was infused during coronary hypopeffusion (18.2 ml/10Qg/min, 20 % of the 
control), coronary blood flow decreased gradually and approached almost zero (3.4 ml/ 
100g/rain) 20 rain after its administration. Histological examination revealed thromboem- 
boll in the small coronary vessels. During hypoperfusion in the presence of 8-SPT, the 
CP compound attenuated both the reduction in coronary blood flow (3.4 to 17.2 ml/100g/ 
min, p<O.05), and the formation of thromboemboli, and improved contractile (fractional 
shodeniog, -7.1 to -1.0 %, p<0.05), and metabolic dysfunction (lactate extraction ratio, - 
70 to -54 %, p<0.05) of the myocardium. 
Conclusion: Thus, we conclude that a novel antagonist of both GP lib/Ilia and vitronec- 
tin receptors attenuates platelet aggregation and the worsening of the severity of myo- 
cardial ischemia caused by the inhibitor of adenosine receptors. There appears the 
linkage between the signals of adenosine receptors and GP lib/Ilia or vitronectin recep- 
tors in platelet or coronary endothelial cells. 
1099-32 Early Microvascular Reflow Status After Infarct 
Reperfusion Determines Outcome of Postinfarction 
Remodeling Independent of Myocardial Salvage 
Frank Sowen, Sina L Moainie, Joseph H. Gorman, III, Ivan Sa~go, T. Sloane Guy, IV, 
Martin St. John-Sutton, L. Henry Edmunds, Robed C. Gorman, University of 
Pennsylvania, Philadelphia, Pennsylvania. 
BACKGROUND: Prompt opening of the infarct related adery is the treatment of choice 
for acute myocardial infarction (MI). A beneficial effect on left vantricular (LV) function 
often results even in patients in which little myocardium is salvage. We hypothesized that 
this phenomenon is dependent on adequate early microvascular perfusion. METHODS: 
Six sheep were subjected to 1 hour of ischemia followed by reperfusion (group 1). Six 
sheep underwent 6 hours of ischemia followed by reperfusion (group 2) and 7 sheep 
were infarcted without reperfusion (control). The ischemic region in all animals was 23% 
of the LV mass at the apex. Microvascular eflow was studied using LV long axis real time 
contrast echooardiography and microsphere injection dudng ischemia, 30 minutes after 
coronary repeffusion and at 2, 5, and 8 weeks. Echocardiography was used to assess 
changes in LV size and regional function throughout he study period. RESULTS: During 
coronary occlusion all animals demonstrated complete microvascular ischemia. After 30 
minutes of coronary reperfusion, group 1 animals demonstrated microvascular eflow of 
the area at risk while group 2 animals demonstrated complete transmural non-reflow. At 
2 weeks, both groups demonstrated complete return of transmural microvascular blood 
flow that persisted throughout he remainder of study. Control animals never achieved 
reflow in the infarct region. The area at risk remained akinetic in all groups throughout the 
study. At eight weeks LV end-systolic volume increased by 134% in control animals and 
by 114% in group 2 but was unchanged in group 1. CONCLUSION: Early microvascular 
reflow dramatically improves post-infarction LV remodeling independent of myocardial 
salvage. 
1099-47 Impaired Healing in Factor Xlll KO Mice After Myocardial 
Infarction Assessed by Magnetic Resonance Imaging 
Matthias Nahrendorf, Kai Hu, Karl-Heinz Hiller, Christiane Waller, Stefan Gattenl(~)hner, 
Gerhard Dickneite, Axel Haase, Wolfgang R. Bauer, Georg Ertl, Medizinische Klinik, 
W(Jrzburg, Germany, Biophysik EP5, WEIrzburg, Germany, 
Background: Clotting factor Xlll has been shown to have a role in wound healing. We 
therefore studied healing after coronary artery ligation in FXIll KO and wild type mice. 
Methods: Magnetic Resonance Imaging was done 2 days after MI in a 7 T-Siospec usin~ 
an ECG-triggered Cine-FLASH-sequence: slice thickness 1 ram, echo-time 1.2 ms, reso- 
lution 230 ram. MI-size, left and right ventdcular (LV&RV) volumes, cardiac output (CO), 
ejection fraction (EF), wall thickness (WT) and -thickening (SWT) and LV mass were 
determined. To minimize bleeding from the thorecotomy wound, FXIII-free fibrin glue was 
applied. 
Results and Conclusion: All FXIII KO mice died within 3 to 5 days after MI, whereas 
wild type mice, that survived surgery, did not die. Dilatation after MI was not different 
between groups, but systolic global and regional function was impaired when compared 
to wildtype. Unchanged RV volumes suggest that hemorrhage from thoracotomy was not 
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profound. Histology revealed rupture of the infarct area with little inflamatory response to 
ischemia. These data show that FXIII may have a major rote also in healing processes 
post myocardial infarction. 
MRI results, Mean±SEM. • p<0.05 v$ Sham, b p<0.05 ve MI, c p<0.05 va Sham 
FXlIIKO 
Sham wildtype MI wildtype Sham FXIII KO MI FXlll KO 
(n=9) (n=9) (n---.3) (n=5) 
42.0¢4.7 58.4±6.6 34.5±2.7 59.5±11.3 
74±3 57±3 a 63¢8 33±4 a,b,c 
15.3±1.4 16.3±1.5 9.0±1.2 a,b 6.7±1.8 a,b 
61±4 60±7 50±15 37±5 a,c 
40.4±4.1 44.8±3.6 39 .1±4.1  44.8±4.9 
1099"48 Ventricular-Arterial Coupl ing in Nondilated Chronic 
Heart Failure Following Coronary Artery Ligation in 
Mice 
Svetlana A. Voltchikhina, Bryan C, Yacono, Linda Chang, Edward G. Lakatta, Mark I, 
Talan. Nationa/ Institute on Aging, Baltimore, Mary~and. 
We have recently described the evolution of a non-dilated (ND) CHF phenotype in a sub- 
set of mice sustaining a small (<10% of left ventricle) myocardial infarction following cor- 
onary ligation (CL). To further characterize this phenotype we measured ventricular 
elastanca at end-systole (Ees) and end-diastole (Eed) and arterial elastanca (Ea) at 6 
wks following CL via pressure- volume loops (conductance catheter Millar). Ea/Ees rela- 
tionships are generally considered "uncoupled" during CHF. Surprisingly, both Ea and 
Ees increased 2 fold (Ea - 10.6±4.8 mmHg/mL, p<0,001 vs SHAM 4.7±0.82; Ees - 
8.21±2,31, p<0,001 vs SHAM 3.38±0.66), which resulted in optimal values of ventricular- 
arterial (VA) coupling (Ea/Ees) (1.3±0.3) not different from SHAM (1.4±0.4). Ejection 
fraction (EF) and stroke volume (SV) were both significantly reduced by 34% and 45% vs 
SHAM (78,9±5.8% and 14.2±1.5mL), but preload adjusted maximal power (PAMP) 
remained not different from SHAM; end-diastolic pressure was increased (10.4±3.6 vs 
5.7±t.4mmHg in SHAM, p<0.05) as well as Eed (0.42±0.11 vs 0.27±0.09 in SHAM, 
p<0.05). Following Isoproterenol infusion both Ea and Ees were reduced by 37% and 
49% without change in VA coupling. Eed declined by 23% (p<0,05 vs baseline) and both 
SV and EF increased to levels similar to SHAM. Thus, while NDCHF heads at 8 wks post 
CL are stiffer at both end-diastole and end-systole with optimal VA coupling and normal 
PAMP, yet Ees reserve is diminished in response to isoproterenol challenge. 
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1100 Perfusion: Myocardium Interrelationships 
in Acute Coronary Syndromes 
Monday, March 18, 2002, Noon-2:00 p.m. 
Georgia World Congress Center, Hall G 
Presentation Hour: 1:00 p.m.-2:00 p.m. 
1100-38 Correlation Between ST Resolution and Anglographic 
Findings in ST Elevation Myocardial infarction 
Marc S. Sabatine, David A. Morrow, Hein Heidbuchel, James A. de Lemos. Soetkin 
Vlassak, Howard A. Cooper, Kristin C. Schuhwerk, Sabina A. Murphy, Carolyn H. 
McCabe, Robed P. Giugliano, Elliott M. Antman, Michael Gibson, Eugene Braunwald, 
Frans Van de Werf, Brigham and Women's Hospital, Boston, Massachusetts, University 
Hospital Gasthuisberg, Leuven, Belgium. 
Background: TIMI flow grade (TFG) and TIMI myocardial perfusion grade (TMPG) are 
angiographic markers of epicardial and myocardial reperfusion, respectively. ST resolu- 
tion (STRes) is a convenient noninvasive marker of reperfusion. We hypothesized that 
STRes reflects both epicardial and myocardial reperfusion. 
Methods: We analyzed 60 minute ECG and angiographic data on 469 ST elevation MI 
patients who received fibrinolytic therapy. STRes was categorized as complete (>70%), 
partial (30-70%) and none (<30%). TFG was categorized as 0/1, 2, and 3. TMPG was 
dichotomized as 0/1 (closed microvasculature) vs 2/3 (open microvasculature). 
Results: STRes improved with better TFG (Fig 1, p<0.001) and with an open microvas* 
culature (Fig 2, p<0.001). In a multivadable logistic regression model, both a patent (TFG 
2/3) infarct-related artery (OR 6.8, p<0.001) and an open microvasculature (OR 2.2, 
p<0.001) were independent determinants of complete STRes. 
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Conclusion: STRes is related to both TFG and TMPG. As a marker of successful fibrin- 
olysis, STRes appears to integrate both epicardial and myocardial perfusion, and this 
may help explain its ability to predict clinical outcome. 
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1100-39 Predictive Value of 60-Minute ST Segment Resolution in 
Electrocardiogram After Lytic Therapy in Patients With 
Acute Myocardial infarction: Results From the GUSTO 
V-RESTART Study 
Femando A. Cure. Marco Roffi, Narcis Pasca, Katherine E. Wolski, Eric J. Topoi, Michael 
S. Lauer, Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: Complete ST-segment elevation resolution at 90 and 180 minutes after 
reparfusion therapy identifies patients with a low mortality risk. This study analyzed the 
extent of 60-minute ST-segment resolution after lytic therapy from the GUSTO V-AMI trial 
that compared reteplase vs. reteplase/abciximab. 
Methods: This prospective study enrolled 1764 patient with ST-segment elevation MI. A 
baseline and 60-minute ECG was analyzed by a core lab to categorize 4 groups: com- 
plete resolution (>70%), partial resolution (<70%-30%), no resolution (<30%) and wors- 
ening ST-segment. 
Reeults: The results are summarized in the table. 
60-minute ECG Complete Padial No Worsening ST 
resolution resolution resolution 
N patients 584 500 272 408 
Population (%) 33 28 15 23 
30-Mortality 2.0 5.2 5.6 8.1 
(%)* 
* ManteI-Haenszel p < 0.001 
A logistic regression model for the 30-day mortality adjusting for the propensity score of 
having a complete ST-segment resolution was performed. Patients with complete resolu- 
tion (OR 0.4, p=0.009), age >75 (OR 6.8, p<0.001), Killip class ->2 (OR 1.9, p=0.049) and 
pdor history of heart failure (OR 4.4, p=0.002) independently correlated with 30-day mor- 
tality. 
Conclusion: Prognosis can be easily assessed as early as 60 minutes after administra- 
tionof lytic therapy in patients with acute MI using the 12-lead ECG. Patients with com- 
plete ST-segment resolution have a particularly low mortality rate compared to those with 
partial; no resolution, and worsening ST-segment who have a 2, 3 and 4-fold increased 
risk, respectively. This timing may be important for clinical decision-making. 
1100-40 Comparison of TIMI Myocardial Perfusion Grade With 
Coronary Flow Reserve for Prediction of Recovery of LV 
Function and LV Remodeling in Acute Myocardial 
Infarction 
So-Yeon Choi, Seung-Jea Tahk, Zhe-Xun Lian, Myeong-Ho ¥oon, Hong-Seok Lira, ll- 
Hyun Cho, Tee-Young Choi, Hyuk-Jae Chang, Gyo-Seung Hwang, Joon-Han Shin, Han- 
Soo Kim, Byung-il W. Choi, Ajou University, Suwon, South Korea. 
Background: It has been reported that a simple angiographic method, the TIMI myocar- 
dial perfusion (TMP) grade could assess viability of myocardium in patients with acute 
myocardial infarction(AMI) after thrembolytic therapy. This study was designed to evalu- 
ate the value of TMP grade itself and correlation with coronary flow reserve (CFR) in the 
prediction of LV ventricular volume and functional change after percutaneous coronary 
intervention (PCt) in AMI. Methods: To avoid the effect of epicardial stenosis, we mea- 
sured CFR and TMP grade after successful elective intervention (residual diameter 
stenosis <30%, TIMI flow >2) in 83 patients (mean age 55±1 years, 18 female) with AMI 
within 7days after symptom onset. To evaluate the area of ischemic injury as a whole, 
CFR measured at distal segment adjacent to angioplasty site by Doppler wire. TMP 
grade 0 was defined as no apparent issue-level perfusion in the distribution of the culprit 
artery; TMP grade 1 indicates presence of myocardial blush but no clearance from the 
microvasculature; TMP grade 2 indicates blush clears slowly; and TMP grade 3 indicates 
that blush begins to clear during washout. Left ventricular end diastolic volume 
index(LVEDVI), left ventricular end systolic volume index(LVESVl), ejection frac- 
tion(LVEF), and left ventricular regional wall motion score index(LVRWMSl) were 
assessed by echocardiography before and after angioplasty(mean 9±7 months). Results: 
After PCI, angiographic TMP grade correlated well with CFR using Doppler wire(r=0.717, 
p<0.001). Post-angioplasty TMP grade was significantly related to the change of LVEDVl 
(r=0.452, p<0.001), LVESVI (r=0.435, p<0.001), LVEF (r=0.281, p=0.01) and LVRWMSI 
(r=0.328, p=0.002). Conclusion: The TMP grade, a simple angiographic method, mea- 
sured after relief of epicardial stenosis, may be useful as a predictor of LV volume and 
functional change in myocardial infarction. It might simply replace CFR for assessment of 
myocardial viability in AMI. 
